The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. diazepam may increase the frequency and/or severity of tonic-clonic seizures, requiring an increase in the dosage of standard anticonvulsant medication. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drug information contained herein may be time sensitive. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Medication Summary Although no psychiatric medications are specifically approved for the treatment of narcissistic personality disorder (NPD), patients often benefit from the use of such. Every effort has been made to ensure that the information provided by Cerner Multum, Inc. Medical device company Vallum Corporation announced that the US Food and Drug Administration (FDA) has approved a polyetheretherketone (PEEK) spine vertebral body Inter-fusion device that uses the PEEKplus nanotextured surface drawn by Vallum’s proprietary and patented accelerated neutral atomic beam (ANAB) technology.
0 kommentar(er)
